Insights into neuroepigenetics through human histone deacetylase PET imaging

Science Translational Medicine

Volumn 8, Issue 351, 2016, Pages

  Wey, Hsiao Ying ^a   Gilbert, Tonya M ^a   Zürcher, Nicole R ^a   She, Angela ^a   Bhanot, Anisha ^a   Taillon, Brendan D ^a   Schroeder, Fredrick A ^a   Wang, Changing ^a   Haggarty, Stephen J ^a   Hooker, Jacob M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE H3; HISTONE H4; MARTINOSTAT C 11; PROGRANULIN; RADIOPHARMACEUTICAL AGENT; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; VORINOSTAT; ADAMANTANE; GRN PROTEIN, HUMAN; HYDROXAMIC ACID; ISOPROTEIN; MARTINOSTAT; SIGNAL PEPTIDE;

ADULT; AMYGDALA; ARTICLE; BRAIN TISSUE; COGNITION; CONTROLLED STUDY; EPIGENETICS; EX VIVO STUDY; FEMALE; GENE EXPRESSION; GENETIC REGULATION; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MALE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEURAL STEM CELL; NEUROEPIGENETICS; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN EXPRESSION; WHITE MATTER; ANALOGS AND DERIVATIVES; BRAIN; CHEMISTRY; CLINICAL TRIAL; METABOLISM; PROCEDURES; YOUNG ADULT;

ADAMANTANE; ADULT; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; HEALTHY VOLUNTEERS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN ISOFORMS; SYNAPTOPHYSIN; YOUNG ADULT;

EID: 84983460404     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaf7551     Document Type: Article

References (40)

1. J. Penney, L.-H. Tsai, Histone deacetylases in memory and cognition. Sci. Signal. 7, re12 (2014).
2. M. Haberland, R. L. Montgomery, E. N. Olson, The many roles of histone deacetylases in development and physiology: Implications for disease and therapy. Nat. Rev. Genet. 10, 32-42 (2009).
3. J.-S. Guan, S. J. Haggarty, E. Giacometti, J.-H. Dannenberg, N. Joseph, J. Gao, T. J. F. Nieland, Y. Zhou, X. Wang, R. Mazitschek, J. E. Bradner, R. A. DePinho, R. Jaenisch, L.-H. Tsai, HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459, 55-60 (2009).
4. S. J. Haggarty, L.-H. Tsai, Probing the role of HDACs and mechanisms of chromatin-mediated neuroplasticity. Neurobiol. Learn. Mem. 96, 41-52 (2011).
5. J. Haettig, D. P. Stefanko, M. L. Multani, D. X. Figueroa, S. C. McQuown, M. A. Wood, HDAC inhibition modulates hippocampus-dependent long-term memory for object location in a CBP-dependent manner. Learn. Mem. 18, 71-79 (2011).
6. J. Gräff, D. Rei, J.-S. Guan, W.-Y. Wang, J. Seo, K. M. Hennig, T. J. F. Nieland, D. M. Fass, P. F. Kao, M. Kahn, S. C. Su, A. Samiei, N. Joseph, S. J. Haggarty, I. Delalle, L.-H. Tsai, An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483, 222-226 (2012).
7. M. Kurita, T. Holloway, A. García-Bea, A. Kozlenkov, A. K. Friedman, J. L. Moreno, M. Heshmati, S. A. Golden, P. J. Kennedy, N. Takahashi, D. M. Dietz, G. Mocci, A. M. Gabilondo, J. Hanks, A. Umali, L. F. Callado, A. L. Gallitano, R. L. Neve, L. Shen, J. D. Buxbaum, M. H. Han, E. J. Nestler, J. J. Meana, S. J. Russo, J. González-Maeso, HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat. Neurosci. 15, 1245-1254 (2012).
8. M. Jakovcevski, R. Bharadwaj, J. Straubhaar, G. Gao, D. P. Gavin, I. Jakovcevski, A. C. Mitchell, S. Akbarian, Prefrontal cortical dysfunction after overexpression of histone deacetylase 1. Biol. Psychiatry 74, 696-705 (2013).
9. J. Gräff, N. F. Joseph, M. E. Horn, A. Samiei, J. Meng, J. Seo, D. Rei, A. W. Bero, T. X. Phan, F. Wagner, E. Holson, J. Xu, J. Sun, R. L. Neve, R. H. Mach, S. J. Haggarty, L.-H. Tsai, Epigenetic priming of memory updating during reconsolidation to attenuate remote fear memories. Cell 156, 261-276 (2014).
10. A. Fischer, F. Sananbenesi, X. Wang, M. Dobbin, L.-H. Tsai, Recovery of learning and memory is associated with chromatin remodelling. Nature 447, 178-182 (2007).
11. H. E. Covington III, I. Maze, Q. C. LaPlant, V. F. Vialou, Y. N. Ohnishi, O. Berton, D. M. Fass, W. Renthal, A. J. Rush III, E. Y. Wu, S. Ghose, V. Krishnan, S. J. Russo, C. Tamminga, S. J. Haggarty, E. J. Nestler, Antidepressant actions of histone deacetylase inhibitors. J. Neurosci. 29, 11451-11460 (2009).
12. F. A. Schroeder, M. C. Lewis, D. M. Fass, F. F. Wagner, Y.-L. Zhang, K. M. Hennig, J. Gale, W.-N. Zhao, S. Reis, D. D. Barker, E. Berry-Scott, S. W. Kim, E. L. Clore, J. M. Hooker, E. B. Holson, S. J. Haggarty, T. L. Petryshen, A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests. PLOS One 8, e71323 (2013).
13. G. Rumbaugh, S. E. Sillivan, E. D. Ozkan, C. S. Rojas, C. R. Hubbs, M. Aceti, M. Kilgore, S. Kudugunti, S. V. Puthanveettil, J. D. Sweatt, J. Rusche, C. A. Miller, Pharmacological selectivity within class I histone deacetylases predicts effects on synaptic function and memory rescue. Neuropsychopharmacology 40, 2307-2316 (2015).
14. B. Cenik, C. F. Sephton, C. M. Dewey, X. Xian, S. Wei, K. Yu, W. Niu, G. Coppola, S. E. Coughlin, S. E. Lee, D. R. Dries, S. Almeida, D. H. Geschwind, F.-B. Gao, B. L. Miller, R. V. Farese Jr., B. A. Posner, G. Yu, J. Herz, Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: Rational therapeutic approach to frontotemporal dementia. J. Biol. Chem. 286, 16101-16108 (2011).
15. K. W. Anderson, J. Chen, M. Wang, N. Mast, I. A. Pikuleva, I. V. Turko, Quantification of histone deacetylase isoforms in human frontal cortex, human retina, and mouse brain. PLOS One 10, e0126592 (2015).
16. M. Malvaez, S. C. McQuown, G. A. Rogge, M. Astarabadi, V. Jacques, S. Carreiro, J. R. Rusche, M. A. Wood, HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner. Proc. Natl. Acad. Sci. U.S.A. 110, 2647-2652 (2013).
17. Y. Zheng, W. Fan, X. Zhang, E. Dong, Gestational stress induces depressive-like and anxiety-like phenotypes through epigenetic regulation of BDNF expression in offspring hippocampus. Epigenetics 11, 150-162 (2016).
18. C. Wang, F. A. Schroeder, H.-Y. Wey, R. Borra, F. F. Wagner, S. Reis, S. W. Kim, E. B. Holson, J. Haggarty, J. M. Hooker, In vivo imaging of histone deacetylases (HDACs) in the central nervous system and major peripheral organs. J. Med. Chem. 57, 7999-8009 (2014).
19. 11C]Martinostat for in vivo HDAC imaging of the brain. ACS Chem. Neurosci. 6, 708-715 (2015).
20. F. H. Bardai, V. Price, M. Zaayman, L. Wang, S. R. D'Mello, Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death. J. Biol. Chem. 287, 35444-35453 (2012).
21. J. Y. Kim, S. Shen, K. Dietz, Y. He, O. Howell, R. Reynolds, P. Casaccia, HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat. Neurosci. 13, 180-189 (2010).
22. D. Martinez Molina, R. Jafari, M. Ignatushchenko, T. Seki, E. A. Larsson, C. Dan, L. Sreekumar, Y. Cao, P. Nordlund, Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84-87 (2013).
23. R. Jafari, H. Almqvist, H. Axelsson, M. Ignatushchenko, T. Lundbäck, P. Nordlund, D. Martinez Molina, The cellular thermal shift assay for evaluating drug target interactions in cells. Nat. Protoc. 9, 2100-2122 (2014).
24. S. Peleg, F. Sananbenesi, A. Zovoilis, S. Burkhardt, S. Bahari-Javan, R. C. Agis-Balboa, P. Cota, J. L. Wittnam, A. Gogol-Doering, L. Opitz, G. Salinas-Riester, M. Dettenhofer, H. Kang, L. Farinelli, W. Chen, A. Fischer, Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328, 753-756 (2010).
25. M. Kilgore, C. A. Miller, D. M. Fass, K. M. Hennig, S. J. Haggarty, J. D. Sweatt, G. Rumbaugh, Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology 35, 870-880 (2010).
26. M. Bantscheff, C. Hopf, M. M. Savitski, A. Dittmann, P. Grandi, A. M. Michon, J. Schlegl, Y. Abraham, I. Becher, G. Bergamini, M. Boesche, M. Delling, B. Dümpelfeld, D. Eberhard, C. Huthmacher, T. Mathieson, D. Poeckel, V. Reader, K. Strunk, G. Sweetman, U. Kruse, G. Neubauer, N. G. Ramsden, G. Drewes, Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat. Biotechnol. 29, 255-265 (2011).
27. I. Becher, A. Dittmann, M. M. Savitski, C. Hopf, G. Drewes, M. Bantscheff, Chemoproteomics reveals time-dependent binding of histone deacetylase inhibitors to endogenous repressor complexes. ACS Chem. Biol. 9, 1736-1746 (2014).
28. C. Rossi, A. Angelucci, L. Costantin, C. Braschi, M. Mazzantini, F. Babbini, M. E. Fabbri, L. Tessarollo, L. Maffei, N. Berardi, M. Caleo, Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. Eur. J. Neurosci. 24, 1850-1856 (2006).
29. T. Falkenberg, A. K. Mohammed, B. Henriksson, H. Persson, B. Winblad, N. Lindefors, Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neurosci. Lett. 138, 153-156 (1992).
30. H. S. Phillips, J. M. Hains, M. Armanini, G. R. Laramee, S. A. Johnson, J. W. Winslow, BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7, 695-702 (1991).
31. M. J. Hawrylycz, E. S. Lein, A. L. Guillozet-Bongaarts, E. H. Shen, L. Ng, J. A. Miller, L. N. van de Lagemaat, K. A. Smith, A. Ebbert, Z. L. Riley, C. Abajian, C. F. Beckmann, A. Bernard, D. Bertagnolli, A. F. Boe, P. M. Cartagena, M. M. Chakravarty, M. Chapin, J. Chong, R. A. Dalley, B. David Daly, C. Dang, S. Datta, N. Dee, T. A. Dolbeare, V. Faber, D. Feng, D. R. Fowler, J. Goldy, B. W. Gregor, Z. Haradon, D. R. Haynor, J. G. Hohmann, S. Horvath, R. E. Howard, A. Jeromin, J. M. Jochim, M. Kinnunen, C. Lau, E. T. Lazarz, C. Lee, T. A. Lemon, L. Li, Y. Li, J. A. Morris, C. C. Overly, P. D. Parker, S. E. Parry, M. Reding, J. J. Royall, J. Schulkin, P. A. Sequeira, C. R. Slaughterbeck, S. C. Smith, A. J. Sodt, S. M. Sunkin, B. E. Swanson, M. P. Vawter, D. Williams, P. Wohnoutka, H. Ronald Zielke, D. H. Geschwind, P. R. Hof, S. M. Smith, C. Koch, S. G. N. Grant, A. R. Jones, An anatomically comprehensive atlas of the adult human transcriptome. Nature 489 391-399 (2012).
32. D. Izquierdo-Garcia, A. E. Hansen, S. Förster, D. Benoit, S. Schachoff, S. Fürst, K. T. Chen, D. B. Chonde, C. Catana, An SPM8-based approach for attenuation correction combining segmentation and nonrigid template formation: Application to simultaneous PET/MR brain imaging. J. Nucl. Med. 55, 1825-1830 (2014).
33. C. Catana, T. Benner, A. van der Kouwe, L. Byars, M. Hamm, D. B. Chonde, C. J. Michel, G. El Fakhri, M. Schmand, A. G. Sorensen, MRI-assisted PET motion correction for neurologic studies in an integrated MR-PET scanner. J. Nucl. Med. 52, 154-161 (2011).
34. M. Jenkinson, P. Bannister, M. Brady, S. Smith, Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17, 825-841 (2002).
35. A. M. Dale, B. Fischl, M. I. Sereno, Cortical surface-based analysis: I. Segmentation and surface reconstruction. Neuroimage 9, 179-194 (1999).
36. S. M. Smith, M. Jenkinson, M. W. Woolrich, C. F. Beckmann, T. E. Behrens, H. Johansen-Berg, P. R. Bannister, M. De Luca, I. Drobnjak, D. E. Flitney, R. K. Niazy, J. Saunders, J. Vickers, Y. Zhang, N. De Stefano, J. M. Brady, P. M. Matthews, Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 (suppl 1), S208-S219 (2004).
37. N. Tzourio-Mazoyer, B. Landeau, D. Papathanassiou, F. Crivello, O. Etard, N. Delcroix, B. Mazoyer, M. Joliot, Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15, 273-289 (2002).
38. C. A. Schneider, W. S. Rasband, K. W. Eliceiri, NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675 (2012).
39. S. D. Sheridan, K. M. Theriault, S. A. Reis, F. Zhou, J. M. Madison, L. Daheron, J. F. Loring, S. J. Haggarty, Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLOS One 6, e26203 (2011).
40. W.-N. Zhao, C. Cheng, K. M. Theriault, S. D. Sheridan, L.-H. Tsai, S. J. Haggarty, A high-throughput screen for Wnt/β-catenin signaling pathway modulators in human iPSC-derived neural progenitors. J. Biomol. Screen. 17, 1252-1263 (2012).